The third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, bod...

As the impact of the pandemic abates in the country, its impact on Indian pharma seems to be wearing off - both on the ground as well as bo...

A difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.

We are happy with the acceleration of the US pipeline, says Cipla’s Global CFO.

Compensation packages are starting to match the growing challenges that the new-age CFO has to face, said Santrupt Misra, director, group h...

Last month, NS Kannan, who served as a CFO at ICICI Bank, was appointed the CEO of ICICI Prudential Life Insurance Company.

The company reported revenues of Rs 15,219 crore, growing 6 per cent, with income from the India operations seeing a 6.3 per cent jump at R...

Today, CFOs are the most sought-after candidates to occupy the corner room, thanks to changed business environment and an evolved role.

"We will operate in across the channels and yes we have a good partner and we believe we will get our fair share of the market."

CFOs are increasingly taking centre stage in boardrooms and the churn in their ranks in India Inc. has been the highest in 2016, with over ...

Until recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in ...

They are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...

Cipla said in a June 8 announcement to stock exchanges, Kedar Upadhye will be joining the organization as its Global chief financial office...

India’s third-largest drug maker Cipla has reshuffled its senior management team, the third time it’s doing so in as many years.

Overall year is well intact & as we have looked our April & May performance, we will be able to get the full year 2014-2015 closer to what ...

ET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.

New brand launches in the local drug market have declined over the last few years as the number of original drugs going off patent has come...